KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for ACM Research (ACMR) over the last 3 years, with Q3 2025 value amounting to $8.0 million.

  • ACM Research's Asset Writedowns and Impairment rose 10942.22% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 14948.51%. This contributed to the annual value of $13.5 million for FY2024, which is 39314.12% up from last year.
  • ACM Research's Asset Writedowns and Impairment amounted to $8.0 million in Q3 2025, which was up 10942.22% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, ACM Research's Asset Writedowns and Impairment ranged from a high of $8.0 million in Q3 2025 and a low of -$9000.0 during Q1 2025
  • In the last 3 years, ACM Research's Asset Writedowns and Impairment had a median value of $1.1 million in 2023 and averaged $2.3 million.
  • In the last 5 years, ACM Research's Asset Writedowns and Impairment skyrocketed by 60254.78% in 2024 and then plummeted by 10076.86% in 2025.
  • Over the past 3 years, ACM Research's Asset Writedowns and Impairment (Quarter) stood at $1.1 million in 2023, then skyrocketed by 602.55% to $7.7 million in 2024, then increased by 4.21% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $1.4 million for Q2 2025, and -$9000.0 during Q1 2025.